- Home
- BLKB vs OGN Comparison
BLKB vs OGN Comparison
Compare BLKB & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLKB
- OGN
- Stock Information
- Founded
- BLKB 1981
- OGN 1923
- Country
- BLKB United States
- OGN United States
- Employees
- BLKB N/A
- OGN N/A
- Industry
- BLKB Computer Software: Prepackaged Software
- OGN Biotechnology: Pharmaceutical Preparations
- Sector
- BLKB Technology
- OGN Health Care
- Exchange
- BLKB Nasdaq
- OGN Nasdaq
- Market Cap
- BLKB 3.9B
- OGN 4.0B
- IPO Year
- BLKB 2004
- OGN N/A
- Fundamental
- Price
- BLKB $79.72
- OGN $14.83
- Analyst Decision
- BLKB Hold
- OGN Hold
- Analyst Count
- BLKB 3
- OGN 3
- Target Price
- BLKB $86.67
- OGN $21.33
- AVG Volume (30 Days)
- BLKB 156.4K
- OGN 2.6M
- Earning Date
- BLKB 02-14-2025
- OGN 02-13-2025
- Dividend Yield
- BLKB N/A
- OGN 7.48%
- EPS Growth
- BLKB N/A
- OGN 120.97
- EPS
- BLKB 0.99
- OGN 5.04
- Revenue
- BLKB $1,148,274,000.00
- OGN $6,409,000,000.00
- Revenue This Year
- BLKB $6.75
- OGN $3.35
- Revenue Next Year
- BLKB $4.32
- OGN $1.88
- P/E Ratio
- BLKB $79.62
- OGN $2.96
- Revenue Growth
- BLKB 5.81
- OGN 4.21
- 52 Week Low
- BLKB $66.47
- OGN $13.87
- 52 Week High
- BLKB $88.95
- OGN $23.10
- Technical
- Relative Strength Index (RSI)
- BLKB 61.21
- OGN 38.98
- Support Level
- BLKB $75.09
- OGN $14.82
- Resistance Level
- BLKB $78.32
- OGN $16.62
- Average True Range (ATR)
- BLKB 1.42
- OGN 0.46
- MACD
- BLKB 0.40
- OGN -0.15
- Stochastic Oscillator
- BLKB 100.00
- OGN 0.28
About BLKB Blackbaud Inc.
Founded in 1981, Blackbaud provides software solutions designed to serve the "social good" community, including nonprofits, foundations, corporations, educational institutions, healthcare institutions, and individual change agents. Through M&A and organic product development efforts, the company has also moved into related areas outside core fundraising, notably into K-12 schools. The firm enables more than $100 billion in donations annually across a customer base in excess of 40,000 customers in over 100 countries.
About OGN Organon & Co.
Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars, and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.